季報
季度報告
10-Q
2026-08-10
美國公共教育集團第二季收入增5.5% 淨利潤977萬美元轉虧為盈
AI 繁中摘要
美國公共教育集團(American Public Education, Inc.,納斯達克:APEI)公佈截至2026年6月30日止第二季度及上半年業績(10-Q申報)。集團期內完成架構整合,將旗下三所院校合併為單一認可學府American Public University System,並成功再融資,財務表現明顯改善。📊
業績重點(未經審核):
- 第二季收入1.717億美元,按年增長5.5%(去年同期1.628億);上半年收入3.465億美元,增長5.8%。
- 第二季淨利潤977萬美元,每股攤薄盈利0.52美元;去年同期淨虧損32.4萬美元(受優先股贖回拖累)。上半年淨利潤2,750萬美元,每股1.46美元。
- 兩大分部中,Military+(軍事教育)第二季收入8,554萬美元,經營溢利2,372萬;Health+(健康護理)收入8,622萬美元,經營溢利30.8萬,成功轉虧為盈。
融資及現金流:
- 3月簽訂新信貸協議,取得9,000萬美元定期貸款及4,000萬美元循環信貸,償還原有約9,640萬美元貸款,並錄得170萬美元債務清償虧損。截至6月底總債務約8,730萬美元。
- 集團開始配置短期投資,持有約7,630萬美元國債及商業票據;現金及受限現金共1.465億美元。上半年經營現金流7,544萬美元,按年大增45%。
- 期內回購約880萬美元普通股,並已全數贖回優先股,消除相關股息及攤薄影響。
管理層展望及影響:
- 8月初獲教育部批准完成院校合併,預期可簡化營運、提升資源運用效率;管理層對護理教育需求維持樂觀,Health+商譽減值測試亦無需計提減值。
- 新貸款利率較低,利息開支按年下降,配合優先股贖回,對股東盈利有正面作用。整體而言,集團財務狀況穩健,符合所有財務契約要求。✅
展開英文正文
apei-20260630false2026Q2000120179212/31P1Yhttp://www.americanpubliceducation.com/20260630#LeaseLiabilityCurrenthttp://www.americanpubliceducation.com/20260630#LeaseLiabilityCurrenthttp://www.americanpubliceducation.com/20260630#LeaseLiabilityNoncurrenthttp://www.americanpubliceducation.com/20260630#LeaseLiabilityNoncurrentApril 30, 20273519,600xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesapei:institutionapei:segmentapei:campusapei:statexbrli:pure00012017922026-01-012026-06-3000012017922026-08-0600012017922026-06-3000012017922025-12-3100012017922026-04-012026-06-3000012017922025-04-012025-06-3000012017922025-01-012025-06-300001201792us-gaap:PreferredStockMember2025-12-310001201792us-gaap:CommonStockMember2025-12-310001201792us-gaap:AdditionalPaidInCapitalMember2025-12-310001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001201792us-gaap:RetainedEarningsMember2025-12-310001201792us-gaap:CommonStockMember2026-01-012026-03-310001201792us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-3100012017922026-01-012026-03-310001201792us-gaap:RetainedEarningsMember2026-01-012026-03-310001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001201792us-gaap:PreferredStockMember2026-03-310001201792us-gaap:CommonStockMember2026-03-310001201792us-gaap:AdditionalPaidInCapitalMember2026-03-310001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001201792us-gaap:RetainedEarningsMember2026-03-3100012017922026-03-310001201792us-gaap:CommonStockMember2026-04-012026-06-300001201792us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001201792us-gaap:RetainedEarningsMember2026-04-012026-06-300001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300001201792us-gaap:PreferredStockMember2026-06-300001201792us-gaap:CommonStockMember2026-06-300001201792us-gaap:AdditionalPaidInCapitalMember2026-06-300001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300001201792us-gaap:RetainedEarningsMember2026-06-300001201792us-gaap:PreferredStockMember2024-12-310001201792us-gaap:CommonStockMember2024-12-310001201792us-gaap:AdditionalPaidInCapitalMember2024-12-310001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001201792us-gaap:RetainedEarningsMember2024-12-3100012017922024-12-310001201792us-gaap:RetainedEarningsMember2025-01-012025-03-3100012017922025-01-012025-03-310001201792us-gaap:CommonStockMember2025-01-012025-03-310001201792us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001201792us-gaap:PreferredStockMember2025-03-310001201792us-gaap:CommonStockMember2025-03-310001201792us-gaap:AdditionalPaidInCapitalMember2025-03-310001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001201792us-gaap:RetainedEarningsMember2025-03-3100012017922025-03-310001201792us-gaap:RetainedEarningsMember2025-04-012025-06-300001201792us-gaap:PreferredStockMember2025-04-012025-06-300001201792us-gaap:CommonStockMember2025-04-012025-06-300001201792us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001201792us-gaap:PreferredStockMember2025-06-300001201792us-gaap:CommonStockMember2025-06-300001201792us-gaap:AdditionalPaidInCapitalMember2025-06-300001201792us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001201792us-gaap:RetainedEarningsMember2025-06-3000012017922025-06-300001201792apei:Building1Memberapei:AmericanPublicUniversitySystemSegmentMember2025-03-310001201792apei:Building1Memberapei:AmericanPublicUniversitySystemSegmentMember2025-01-012025-03-310001201792apei:Building1Memberapei:AmericanPublicUniversitySystemSegmentMember2025-06-300001201792us-gaap:LandMemberapei:AmericanPublicUniversitySystemSegmentMember2025-03-310001201792apei:Building2Memberapei:AmericanPublicUniversitySystemSegmentMember2025-06-300001201792us-gaap:SeriesAPreferredStockMember2025-06-012025-06-300001201792us-gaap:SeriesAPreferredStockMember2025-04-012025-06-300001201792us-gaap:SeriesAPreferredStockMember2025-06-300001201792us-gaap:SeriesAPreferredStockMember2026-01-012026-06-300001201792us-gaap:SeriesAPreferredStockMember2026-04-012026-06-300001201792us-gaap:SeriesAPreferredStockMember2025-01-012025-06-300001201792us-gaap:CostOfGoodsAndServicesSold2026-04-012026-06-300001201792us-gaap:CostOfGoodsAndServicesSold2025-04-012025-06-300001201792us-gaap:CostOfGoodsAndServicesSold2026-01-012026-06-300001201792us-gaap:CostOfGoodsAndServicesSold2025-01-012025-06-300001201792us-gaap:SellingAndMarketingExpense2026-04-012026-06-300001201792us-gaap:SellingAndMarketingExpense2025-04-012025-06-300001201792us-gaap:SellingAndMarketingExpense2026-01-012026-06-300001201792us-gaap:SellingAndMarketingExpense2025-01-012025-06-300001201792us-gaap:GeneralAndAdministrativeExpense2026-04-012026-06-300001201792us-gaap:GeneralAndAdministrativeExpense2025-04-012025-06-300001201792us-gaap:GeneralAndAdministrativeExpense2026-01-012026-06-300001201792us-gaap:GeneralAndAdministrativeExpense2025-01-012025-06-300001201792apei:IncentiveBasedCompensationPlanMember2026-04-012026-06-300001201792apei:IncentiveBasedCompensationPlanMember2026-01-012026-06-300001201792apei:IncentiveBasedCompensationPlanMember2025-04-012025-06-300001201792apei:IncentiveBasedCompensationPlanMember2025-01-012025-06-300001201792us-gaap:CommercialPaperMember2026-06-300001201792us-gaap:USTreasurySecuritiesMember2026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberus-gaap:IntersegmentEliminationMember2026-04-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMember2026-04-012026-06-300001201792apei:GraduationFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:GraduationFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:GraduationFeesMemberus-gaap:IntersegmentEliminationMember2026-04-012026-06-300001201792apei:GraduationFeesMember2026-04-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberus-gaap:IntersegmentEliminationMember2026-04-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMember2026-04-012026-06-300001201792apei:OtherFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:OtherFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792apei:OtherFeesMemberus-gaap:IntersegmentEliminationMember2026-04-012026-06-300001201792apei:OtherFeesMember2026-04-012026-06-300001201792us-gaap:OperatingSegmentsMemberapei:MilitarySegmentMember2026-04-012026-06-300001201792us-gaap:OperatingSegmentsMemberapei:HealthSegmentMember2026-04-012026-06-300001201792us-gaap:IntersegmentEliminationMember2026-04-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberus-gaap:IntersegmentEliminationMember2025-04-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMember2025-04-012025-06-300001201792apei:GraduationFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:GraduationFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:GraduationFeesMemberus-gaap:IntersegmentEliminationMember2025-04-012025-06-300001201792apei:GraduationFeesMember2025-04-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberus-gaap:IntersegmentEliminationMember2025-04-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMember2025-04-012025-06-300001201792apei:OtherFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:OtherFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792apei:OtherFeesMemberus-gaap:IntersegmentEliminationMember2025-04-012025-06-300001201792apei:OtherFeesMember2025-04-012025-06-300001201792us-gaap:OperatingSegmentsMemberapei:MilitarySegmentMember2025-04-012025-06-300001201792us-gaap:OperatingSegmentsMemberapei:HealthSegmentMember2025-04-012025-06-300001201792us-gaap:IntersegmentEliminationMember2025-04-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberus-gaap:IntersegmentEliminationMember2026-01-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMember2026-01-012026-06-300001201792apei:GraduationFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:GraduationFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:GraduationFeesMemberus-gaap:IntersegmentEliminationMember2026-01-012026-06-300001201792apei:GraduationFeesMember2026-01-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberus-gaap:IntersegmentEliminationMember2026-01-012026-06-300001201792apei:TextbookAndOtherCourseMaterialsMember2026-01-012026-06-300001201792apei:OtherFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:OtherFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792apei:OtherFeesMemberus-gaap:IntersegmentEliminationMember2026-01-012026-06-300001201792apei:OtherFeesMember2026-01-012026-06-300001201792us-gaap:OperatingSegmentsMemberapei:MilitarySegmentMember2026-01-012026-06-300001201792us-gaap:OperatingSegmentsMemberapei:HealthSegmentMember2026-01-012026-06-300001201792us-gaap:IntersegmentEliminationMember2026-01-012026-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMemberus-gaap:IntersegmentEliminationMember2025-01-012025-06-300001201792apei:InstructionalServicesNetOfGrantsAndScholarshipsMember2025-01-012025-06-300001201792apei:GraduationFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:GraduationFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:GraduationFeesMemberus-gaap:IntersegmentEliminationMember2025-01-012025-06-300001201792apei:GraduationFeesMember2025-01-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMemberus-gaap:IntersegmentEliminationMember2025-01-012025-06-300001201792apei:TextbookAndOtherCourseMaterialsMember2025-01-012025-06-300001201792apei:OtherFeesMemberapei:MilitarySegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:OtherFeesMemberapei:HealthSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792apei:OtherFeesMemberus-gaap:IntersegmentEliminationMember2025-01-012025-06-300001201792apei:OtherFeesMember2025-01-012025-06-300001201792us-gaap:OperatingSegmentsMemberapei:MilitarySegmentMember2025-01-012025-06-300001201792us-gaap:OperatingSegmentsMemberapei:HealthSegmentMember2025-01-012025-06-300001201792us-gaap:IntersegmentEliminationMember2025-01-012025-06-300001201792apei:CoursesInProgressMember2026-06-300001201792apei:FutureCoursesMember2026-06-300001201792apei:CoursesInProgressMember2025-12-310001201792apei:FutureCoursesMember2025-12-310001201792apei:HealthSegmentMember2026-01-012026-06-300001201792us-gaap:EmployeeStockMember2026-04-012026-06-300001201792us-gaap:EmployeeStockMember2026-01-012026-06-300001201792us-gaap:EmployeeStockMember2025-04-012025-06-300001201792us-gaap:EmployeeStockMember2025-01-012025-06-300001201792us-gaap:RestrictedStockMember2025-04-012025-06-300001201792us-gaap:RestrictedStockMember2025-01-012025-06-300001201792us-gaap:SeniorNotesMemberapei:CreditAgreementMember2026-03-090001201792us-gaap:LineOfCreditMemberapei:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2026-03-090001201792us-gaap:LineOfCreditMemberapei:CreditAgreementMemberus-gaap:LetterOfCreditMember2026-03-090001201792us-gaap:LineOfCreditMemberapei:CreditAgreementMemberapei:SubfacilityForSwingLineLoansMember2026-03-090001201792us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2026-03-090001201792us-gaap:LoansPayableMemberapei:TermLoanMember2026-03-092026-03-090001201792us-gaap:SecuredDebtMemberapei:SeniorSecuredTermLoanFacilityMember2026-03-090001201792us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2026-03-092026-03-090001201792us-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2026-03-092026-03-090001201792us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2026-03-092026-03-090001201792us-gaap:LineOfCreditMembersrt:MinimumMember2026-03-092026-03-090001201792us-gaap:LineOfCreditMembersrt:MaximumMember2026-03-092026-03-090001201792us-gaap:LineOfCreditMember2026-03-090001201792us-gaap:SeniorNotesMemberapei:CreditAgreementMember2026-06-300001201792us-gaap:SeniorNotesMemberapei:CreditAgreementMemberapei:FirstThreeQuarterlyPaymentsMember2026-01-012026-06-300001201792us-gaap:SeniorNotesMemberapei:CreditAgreementMemberapei:FollowingEightQuarterlyPaymentsMember2026-01-012026-06-300001201792us-gaap:SeniorNotesMemberapei:CreditAgreementMemberapei:FinalEightQuarterlyPaymentsMember2026-01-012026-06-300001201792us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2026-06-300001201792us-gaap:LineOfCreditMember2026-06-300001201792us-gaap:SecuredDebtMemberapei:SeniorSecuredTermLoanFacilityMember2026-06-300001201792us-gaap:SecuredDebtMemberapei:SeniorSecuredTermLoanFacilityMember2025-12-310001201792us-gaap:CorporateNonSegmentMember2026-04-012026-06-300001201792us-gaap:CorporateNonSegmentMember2025-04-012025-06-300001201792us-gaap:CorporateNonSegmentMember2026-01-012026-06-300001201792us-gaap:CorporateNonSegmentMember2025-01-012025-06-300001201792us-gaap:OperatingSegmentsMember2026-04-012026-06-300001201792us-gaap:OperatingSegmentsMember2025-04-012025-06-300001201792us-gaap:OperatingSegmentsMember2026-01-012026-06-300001201792us-gaap:OperatingSegmentsMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:DepartmentOfDefenseTuitionAssistanceProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:DepartmentOfDefenseTuitionAssistanceProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:DepartmentOfDefenseTuitionAssistanceProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:DepartmentOfDefenseTuitionAssistanceProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:MilitarySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:RasmussenUniversitySegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:TitleIVProgramsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:CashAndOtherSourcesMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2025-01-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2026-04-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2025-04-012025-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2026-01-012026-06-300001201792us-gaap:CustomerConcentrationRiskMemberapei:VeteranEducationBenefitsMemberus-gaap:RevenueFromContractWithCustomerMemberapei:HealthSegmentMemberapei:HondrosCollegeOfNursingSegmentMember2025-01-012025-06-300001201792apei:JamesKenigsbergMember2026-04-012026-06-300001201792apei:JamesKenigsbergMember2026-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-33810 AMERICAN PUBLIC EDUCATION, INC. (Exact name of registrant as specified in its charter) Delaware01-0724376 (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) 111 West Congress Street, Charles Town, West Virginia 25414 (Address of principal executive offices)(Zip Code) (304) 724-3700 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $.01 par valueAPEINasdaq Global Select Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐Accelerated filer ☒ Non-accelerated filer ☐Smaller reporting company☐ Emerging growth company☐ If an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ The total number of shares of common stock outstanding as of August 6, 2026, was 18,301,543. AMERICAN PUBLIC EDUCATION, INC. FORM 10-Q INDEX Page PART I – FINANCIAL INFORMATION Item 1. Financial Statements 3 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3. Quantitative and Qualitative Disclosures About Market Risk 36 Item 4. Controls and Procedures 36 PART II – OTHER INFORMATION Item 1. Legal Proceedings 36 Item 1A. Risk Factors 36 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 37 Item 3. Defaults Upon Senior Securities 37 Item 4. Mine Safety Disclosures 37 Item 5. Other Information 38 Item 6. Exhibits 39 SIGNATURES 40 2 PART I – FINANCIAL INFORMATION Item 1. Financial Statements AMERICAN PUBLIC EDUCATION, INC. Consolidated Balance Sheets (In thousands, except share and per share amounts) As of June 30, 2026As of December 31, 2025 ASSETS(Unaudited) Current assets: Cash, cash equivalents, and restricted cash (Note 2)$146,548 $176,499 Short-term investments (Note 3)76,256 — Accounts receivable, net of allowance of $21,754 in 2026 and $21,113 in 2025 35,512 65,662 Prepaid expenses20,068 14,197 Income tax receivable4,136 3,458 Total current assets282,520 259,816 Property and equipment, net69,534 70,598 Operating lease assets, net (Note 5)55,390 57,686 Deferred income taxes36,613 39,176 Intangible assets, net (Note 6)28,221 28,221 Goodwill (Note 6)59,593 59,593 Other assets, net5,875 6,328 Total assets$537,746 $521,418 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable$5,148 $4,822 Accrued compensation and benefits20,797 22,463 Accrued liabilities20,349 13,375 Deferred revenue and student deposits23,928 23,016 Lease liabilities, current (Note 5)11,109 11,374 Long-term debt, current (Note 8)5,625 — Total current liabilities86,956 75,050 Lease liabilities, long-term (Note 5)55,098 56,921 Long-term debt, net (Note 8)81,635 94,665 Total liabilities223,689 226,636 Commitments and contingencies (Note 10) Stockholders’ equity: Common stock, $.01 par value; 100,000,000 shares authorized; 18,367,887 and 18,125,860; issued and outstanding in 2026 and 2025 183 181 Additional paid-in capital307,878 311,119 Accumulated other comprehensive loss(7)(18) Retained earnings (deficit)6,003 (16,500) Total stockholders’ equity314,057 294,782 Total liabilities and stockholders’ equity$537,746 $521,418 The accompanying notes are an integral part of these Consolidated Financial Statements. 3 AMERICAN PUBLIC EDUCATION, INC. Consolidated Statements of Income (In thousands, except per share amounts) Three Months Ended June 30,Six Months Ended June 30, 2026202520262025 (Unaudited)(Unaudited) Revenue$171,731 $162,766 $346,469 $327,317 Costs and expenses: Instructional costs and services76,640 78,423 151,270 153,367 Selling and promotional40,115 35,048 77,982 70,253 General and administrative37,492 38,147 73,782 74,554 Depreciation and amortization3,953 4,088 8,107 8,080 Loss on assets held for sale (Note 2)— — — 1,527 Loss on disposals of long-lived assets5 35 159 265 Total costs and expenses158,205 155,741 311,300 308,046 Income from operations before interest and income taxes13,526 7,025 35,169 19,271 Loss on extinguishment of debt (Note 8)— — (1,672)— Interest income (expense), net634 (1,108)(91)(1,995) Income before income taxes14,160 5,917 33,406 17,276 Income tax expense (Note 2)4,387 1,421 5,902 3,887 Net income$9,773 $4,496 $27,504 $13,389 Preferred stock dividends— 1,319 — 2,751 Loss on redemption of preferred stock— 3,501 — 3,501 Net income (loss) available to common stockholders$9,773 $(324)$27,504 $7,137 Income (loss) per common share (Note 7): Basic$0.53 $(0.02)$1.50 $0.40 Diluted$0.52 $(0.02)$1.46 $0.39 Weighted average number of common shares: Basic18,362 18,034 18,322 17,937 Diluted18,810 18,597 18,808 18,496 The accompanying notes are an integral part of these Consolidated Financial Statements. 4 AMERICAN PUBLIC EDUCATION, INC. Consolidated Statements of Comprehensive Income (Loss) (In thousands) Three Months Ended June 30,Six Months Ended June 30, 2026202520262025 (Unaudited)(Unaudited) Net income$9,773 $4,496 $27,504 $13,389 Other comprehensive gain (loss), net of tax: Unrealized loss on short-term investments, net of taxes(7)— (7)— Unrealized gain (loss) on hedging derivatives, net of taxes— 20 — (26) Unrealized (loss) gain, net of taxes(7)20 (7)(26) Reclassification of gain to net income, net of taxes— — 18 5 Reclassifications of gain to net income, net of taxes— — 18 5 Total other comprehensive (loss) gain(7)20 11 (21) Comprehensive income$9,766 $4,516 $27,515 $13,368 The accompanying notes are an integral part of these Consolidated Financial Statements. 5 AMERICAN PUBLIC EDUCATION, INC. Consolidated Statements of Stockholders’ Equity (Unaudited) (In thousands, except share amounts) Additional Paid-in CapitalAccumulated Other Comprehensive Income (loss)Retained Earnings (Deficit)Total Stockholders’ Equity Preferred StockCommon Stock SharesAmountSharesAmount Balance as of December 31, 2025— $— 18,125,860 $181 $311,119 $(18)$(16,500)$294,782 Exercise of stock options— — 470 — 17 — — 17 Issuance of common stock under employee benefit plans— — 480,429 5 (5)— — — Deemed repurchased shares of common and restricted stock for tax withholding— — (177,765)(2)(7,708)— — (7,710) Stock-based compensation— — — — 2,327 — — 2,327 Repurchased and retired shares of common stock— — (17,840)— — — (1,000)(1,000) Other comprehensive income— — — — — 18 — 18 Net income— — — — — — 17,731 17,731 Balance as of March 31, 2026— $— 18,411,154 $184 $305,750 $— $231 $306,165 Exercise of stock options— — 6,925 — 37 — — 37 Issuance of common stock under employee benefit plans— — 22,742 — — — — — Deemed repurchased shares of common and restricted stock for tax withholding— — (2,569)— (141)— — (141) Stock-based compensation— — — — 2,232 — — 2,232 Repurchased and retired shares of common stock— — (70,365)(1)— — (4,001)(4,002) Other comprehensive loss— — — — — (7)— (7) Net income— — — — — — 9,773 9,773 Balance as of June 30, 2026— $— 18,367,887 $183 $307,878 $(7)$6,003 $314,057 The accompanying notes are an integral part of these Consolidated Financial Statements. 6 Additional Paid-in CapitalAccumulated Other Comprehensive LossRetained Earnings (Deficit)Total Stockholders’ Equity Preferred StockCommon Stock SharesAmountSharesAmount Balance as of December 31, 2024400 $39,691 17,712,575 $177 $305,823 $(7)$(41,805)$303,879 Preferred stock dividends— — — — — — (1,432)(1,432) Exercise of stock options— — 14,431 — 143 — — 143 Issuance of common stock under employee benefit plans— — 480,515 5 (5)— — — Deemed repurchased shares of common and restricted stock for tax withholding— — (171,100)(2)(3,691)— — (3,693) Stock-based compensation— — — — 2,263 — — 2,263 Other comprehensive loss— — — — — (41)— (41) Net income— — — — — — 8,893 8,893 Balance as of March 31, 2025400 $39,691 18,036,421 $180 $304,533 $(48)$(34,344)$310,012 Preferred stock dividends— — — — — — (1,319)(1,319) Redemption of preferred stock(400)(39,691)— — — — — (39,691) Loss on redemption of preferred stock— — — — — — (3,501)(3,501) Exercise of stock options— — 8,307 — 15 — — 15 Issuance of common stock under employee benefit plans— — 18,157 — — — — — Deemed repurchased shares of common and restricted stock for tax withholding— — (1,286)— (30)— — (30) Stock-based compensation— — — — 2,238 — — 2,238 Other comprehensive income— — — — — 20 — 20 Net income— — — — — — 4,496 4,496 Balance as of June 30, 2025— $— 18,061,599 $180 $306,756 $(28)$(34,668)$272,240 The accompanying notes are an integral part of these Consolidated Financial Statements. 7 AMERICAN PUBLIC EDUCATION, INC. Consolidated Statements of Cash Flows (In thousands) Six Months Ended June 30, 20262025 (Unaudited) Operating activities Net income$27,504 $13,389 Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization8,107 8,080 Loss on extinguishment of debt1,627 — Amortization of debt issuance costs346 688 Stock-based compensation4,559 4,501 Accretion of investment discounts(348)— Deferred income taxes2,567 1,354 Loss on assets held for sale— 1,527 Loss on disposals of long-lived assets159 265 Changes in operating assets and liabilities: Accounts receivable, net of allowance for bad debt30,150 24,890 Prepaid expenses(5,871)(4,560) Income tax receivable(678)(1,547) Operating leases, net315 (185) Other assets458 (374) Accounts payable326 2,220 Accrued compensation and benefits(1,666)(229) Accrued liabilities6,974 295 Deferred revenue and student deposits912 1,493 Net cash provided by operating activities75,441 51,807 Investing activities Capital expenditures(7,266)(7,600) Purchases of short-term investments(75,919)— Proceeds from the sale of real property— 22,950 Net cash (used in) provided by investing activities(83,185)15,350 Financing activities Cash paid for repurchase of common stock(12,853)(3,723) Cash received from exercise of stock options54 158 Preferred stock dividends paid— (2,751) Cash paid for redemption of preferred stock— (43,096) Cash paid for principal on borrowings and finance leases(97,657)(107) Cash received from borrowings90,000 — Cash paid for debt issuance costs(1,751)— Net cash used in financing activities(22,207)(49,519) Net (decrease) increase in cash, cash equivalents, and restricted cash(29,951)17,638 Cash, cash equivalents, and restricted cash at beginning of period176,499 158,941 Cash, cash equivalents, and restricted cash at end of period$146,548 $176,579 Supplemental disclosure of cash flow information Interest paid$3,321 $4,820 Income taxes paid$4,014 $4,063 The accompanying notes are an integral part of these Consolidated Financial Statements. 8 AMERICAN PUBLIC EDUCATION, INC. Notes to Consolidated Financial Statements Note 1. Nature of the Business American Public Education, Inc., or APEI, together with its subsidiary referred to as the Company, is a provider of online and campus-based postsecondary education to students. Effective March 2, 2026, the Company completed the merger of the legal entities that owned and operated the Company’s three institutions at the time, American Public University System, or APUS, Rasmussen University, or RU, and Hondros College of Nursing, or HCN, with American Public University System, Inc. surviving the merger. On August 4, 2026, the U.S. Department of Education, or ED, approved, and we completed, the Combination of APUS, RU, and HCN into one HLC-accredited institution named American Public University System, or the System. The Company provides education services through the following reportable segments: •Military+ Segment, formerly the APUS Segment, provides online postsecondary education directed primarily at the needs of the military, veterans, extended military and veteran families, and other public service and service-minded communities through American Military University and American Public University. •Health+ Segment, consisting of the businesses that formerly comprised the RU Segment and the HCN Segment, provides nursing- and health sciences-focused education and other postsecondary education, including business, technology, and education, to students through RU and HCN. The System is licensed or otherwise authorized by state authorities to offer education programs to the extent it believes such licenses or authorizations are required, and the System is certified by ED to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs. The accompanying Consolidated Financial Statements reflect the operations of American Public Training LLC, which is referred to herein as Graduate School USA, or GSUSA, through July 25, 2025, or the GSUSA Sale Date. Adjustments to reconcile segment results to the Consolidated Financial Statements are included in Corporate and Other. These adjustments include unallocated corporate activity and eliminations, and, prior to the GSUSA Sale Date, the operational activities of GSUSA. Prior period segment disclosures have been recast to conform to the current period presentation. Please refer to “Note 9. Segment Information” for more information on the Company’s reportable segments. Note 2. Summary of Significant Accounting Policies A summary of the Company’s significant accounting policies follows: Basis of Presentation and Accounting The Company has prepared the accompanying unaudited, interim consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, or GAAP. Business Combinations The Company accounts for business combinations in accordance with Financial Accounting Standards Board Accounting Standards Codification 805, Business Combinations, or FASB ASC 805, which requires companies to use the acquisition method for all business combinations. Under ASC 805, the assets and liabilities of an acquired company are reported at business fair value along with the fair value of acquired intangible assets at the date of acquisition. Goodwill 9 represents the excess of the purchase price of an acquired business over the amount assigned to the assets acquired and liabilities assumed, and the fair value assigned to identifiable intangible assets. Principles of Consolidation The accompanying unaudited interim consolidated financial statements reflect the accounts of APEI and its wholly owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The Company’s reportable segments are determined in accordance with FASB ASC 280, Segment Reporting, and are based upon how the chief operating decision maker, or CODM, analyzes performance and makes decisions. The Company organizes its business across two reportable segments: Military+ and Health+. Each segment represents an educational division that provides a variety of postsecondary academic programs. Unaudited Interim Consolidated Financial Information The unaudited interim Consolidated Financial Statements do not include all the information and notes required by GAAP for audited annual financial statement presentations. In the opinion of management, these statements include all adjustments (consisting of normal recurring adjustments) considered necessary to present a fair statement of the Company’s financial position, results of operations, and cash flows. Operating results for any interim period are not necessarily indicative of the results that may be expected for future periods, including the year ending December 31, 2026. This Quarterly Report on Form 10-Q, or this Quarterly Report, should be read in conjunction with the Consolidated Financial Statements and accompanying notes in its audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, or the Annual Report. Use of Estimates In preparing financial statements in conformity with GAAP, the Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company evaluates these estimates and assumptions on an ongoing basis and bases its estimates on experience, current and expected future conditions and various other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions, and the impact of such differences may be material to the Consolidated Financial Statements. Cash and Cash Equivalents The Company considers all short-term highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash and cash equivalents consist of demand deposits with financial institutions, money market funds, and U.S. Treasury bills. Cash and cash equivalents are Level 1 assets in the fair value reporting hierarchy. Restricted Cash Restricted cash includes funds held for students for unbilled educational services that were received from Title IV programs. As a trustee of these Title IV program funds, the Company is required to maintain and restrict these funds pursuant to the terms of the program participation agreement with ED. Total restricted cash as of June 30, 2026, and December 31, 2025, was $1.2 million and $2.4 million, respectively. Short-Term Investments Investments with original maturities ranging from three months to one year are classified as short-term investments. As of June 30, 2026, the Company considered its short-term investments in investment grade commercial paper and U.S. Treasury securities as available-for-sale securities based on the Company’s intent for the respective securities. Available-for-sale securities are carried at fair value on the accompanying Consolidated Balance Sheets, determined using Level 2 of the hierarchy of valuation inputs, with the use of inputs other than quoted prices that are observable for the assets. Unrealized investment gains and losses, net of tax, are reported as a separate component of other comprehensive income. Accretion of discounts and interest are included in interest income (expense), net. Realized gains and losses, if any, are included in gain (loss) on investments. 10 Assets Held for Sale Assets held for sale represent excess real property located in Charles Town, West Virginia within the Company’s Military+ Segment. The Company classifies long-lived assets as held for sale when the assets are expected to be sold within the next 12 months and meet the other relevant held for sale criteria. As such, the properties are recorded at the lower of the carrying value or fair value, less costs to sell, until such time the assets are sold. In the first quarter of 2025, APUS entered into an agreement to sell a building classified in assets held for sale as of December 31, 2024, for $7.0 million, and recorded a loss of $1.5 million, based on the contract amount less estimated costs to sell of $0.4 million. The loss was included in loss on assets held for sale in the accompanying Consolidated Statements of Income for the six months ended June 30, 2025. The sale was completed in June 2025 for net sales proceeds of $6.6 million. In the first quarter of 2025, APUS completed the sale of an undeveloped parcel of land classified in assets held for sale as of December 31, 2024, for net sales proceeds of $0.5 million. In the second quarter of 2025, APUS completed the sale of a building classified in assets held for sale as of December 31, 2024, for net sales proceeds of $15.9 million. Total cash received from the sale of assets held for sale for the six months ended June 30, 2025, was $23.0 million. There were no assets held for sale as of June 30, 2026, and December 31, 2025. Goodwill and Intangible Assets Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the assets acquired and liabilities assumed, and the fair value of acquired intangible assets at the date of acquisition. Goodwill is not amortized. The Company accounts for goodwill and indefinite-lived intangible assets in accordance with FASB ASC 350, Intangibles Goodwill and Other, and Accounting Standards Update, or ASU, 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The Company’s goodwill and intangible assets are deductible for tax purposes. The Company annually assesses goodwill for impairment, or more frequently if events or circumstances indicate that goodwill might be impaired. Goodwill impairment testing consists of an optional qualitative assessment as well as a quantitative test. The quantitative test compares the fair value of a reporting unit to its carrying value. If the carrying value of the reporting unit is greater than zero and its fair value is greater than its carrying amount, there is no impairment. If the carrying value is greater than the fair value, the difference between the two values is recorded as an impairment. Indefinite-lived and finite-lived intangible assets acquired in business combinations are recorded at fair value on the acquisition date. Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life of the asset. The Company reviews its indefinite-lived and finite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If such assets are not recoverable, a potential impairment loss is recognized to the extent the carrying amount of the assets exceeds the fair value of the assets. For additional details regarding goodwill and intangible assets, please refer to “Note 6. Goodwill and Intangible Assets” to the Consolidated Financial Statements. Series A Senior Preferred Stock The Company redeemed all 400 outstanding shares of the Series A Senior Preferred Stock in June 2025. The loss on redemption of $3.5 million was recorded as a reduction to net income available to common stockholders for the three months ended June 30, 2025 and was calculated as the difference between the consideration paid, excluding dividends, and the book value of the Series A Senior Preferred Stock of $39.6 million. Accordingly, there were no dividends declared or paid on the Series A Senior Preferred Stock during the three and six months ended June 30, 2026. During the three and six months ended June 30, 2025, dividends declared and paid on the Series A Senior Preferred Stock were $1.4 million and $2.8 million, respectively. 11 Fair Value Measurements The Company measures certain financial assets at fair value for disclosure purposes, as well as on a nonrecurring basis when they are deemed to be other-than-temporary impairments. Fair value represents the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. Assets and liabilities recorded at fair value are measured and classified in accordance with a three-tier fair value hierarchy based on the observability of the inputs available in the market used to measure fair value: Level 1 - inputs to the valuation techniques that are quoted prices in active markets for identical assets or liabilities; Level 2 - inputs to the valuation techniques that are other than quoted prices but are observable for the assets or liabilities, either directly or indirectly; or Level 3 - inputs to the valuation techniques that are unobservable for the assets or liabilities. The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Stock-based Compensation The Company accounts for stock-based compensation in accordance with FASB ASC 718, Stock